Bausch Site 122 — Cranberry Township, Pennsylvania

Bausch Site 122 is a clinical research site located in Cranberry Township, Pennsylvania, United States 16066.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Bausch Site 122 has participated in 2 clinical trials.

Therapeutic areas: Dry Eye Disease (DED).

Sponsors: Bausch & Lomb Incorporated.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cranberry Township

Browse all research sites in Pennsylvania · View every site in Cranberry Township

• Magee-Womens Hospital of UPMC,3 St. Francis Way
• Children's Community Pediatrics (CCP-Bass Wolfson Cranberry) of Children's Hospital of Pittsburgh of UPMC
• Scott Christie and Associates PC
• UPMC Hillman Cancer Center - Passavant - Cranberry
• Scott Christie and Associates
• CYS-005 Investigational Site
• Ocular Therapeutix, Inc.
• GSK Investigational Site
• Orasis Investigative Site
• UPMC Hillman Cancer Center Passavant North
• Pfizer Investigational Site
• UPMC Magee at the Lemieux Sports Complex

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Bausch Site 122?

Bausch Site 122 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Bausch Site 122 conducted?

Bausch Site 122 has 2 clinical trials on record. Their work covers Dry Eye Disease (DED).

Is Bausch Site 122 accredited by Crixeo Clinical Trials?

Bausch Site 122 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Bausch Site 122?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.